Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study

PURPOSE: Anlotinib is widely used in the clinical treatment of non-small cell lung cancer (NSCLC), alone or in combination with other anticancer drugs. The aim of this study was to investigate the real-world efficacy and safety of anlotinib-containing regimens. PATIENTS AND METHODS: Confirmed advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Zhao, Qi, Wang, Yanning, Wang, Yongsheng, Zheng, Ming, Ding, Xuansheng, Miao, Liyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505018/
https://www.ncbi.nlm.nih.gov/pubmed/37720175
http://dx.doi.org/10.2147/IJGM.S424777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505018/
https://www.ncbi.nlm.nih.gov/pubmed/37720175
http://dx.doi.org/10.2147/IJGM.S424777

Ejemplares similares